Intracoastal Capital Amends INVO Bioscience Stake

TL;DR

**Intracoastal Capital just updated its INVO Bioscience stake, watch for market reaction!**

AI Summary

Intracoastal Capital, LLC and its managing members, Mitchell P. Kopin and Daniel B. Asher, have filed an amended Schedule 13G/A for INVO Bioscience, Inc. as of December 31, 2023. This filing indicates a change in their beneficial ownership of INVO Bioscience's common stock, $0.0001 par value per share. While the specific change in ownership percentage isn't detailed in the provided text, the amendment signals that their previously reported stake has been altered, which is important for investors as it reflects a shift in a significant holder's position and could influence market sentiment or future corporate actions.

Why It Matters

This filing shows a notable investor, Intracoastal Capital, has changed its position in INVO Bioscience, which can signal their updated confidence in the company's future.

Risk Assessment

Risk Level: medium — The filing indicates a change in a significant holder's position, which could introduce volatility if the change is substantial.

Analyst Insight

Investors should monitor subsequent filings or news from Intracoastal Capital, LLC to understand the nature and magnitude of the change in their INVO Bioscience stake, as this could signal a shift in institutional confidence.

Key Numbers

• 44984F401 — CUSIP Number (identifies INVO Bioscience's Common Stock)
• 0001417926 — Central Index Key (CIK) (identifies INVO Bioscience, Inc.)
• 0001646799 — Central Index Key (CIK) (identifies Intracoastal Capital, LLC)

Key Players & Entities

• INVO Bioscience, Inc. (company) — the subject company whose securities are being reported
• Intracoastal Capital, LLC (company) — the entity filing the SC 13G/A amendment
• Mitchell P. Kopin (person) — a reporting person and group member
• Daniel B. Asher (person) — a group member
• December 31, 2023 (date) — the date of the event requiring the filing
• $0.0001 (dollar_amount) — par value per share of INVO Bioscience Common Stock

Forward-Looking Statements

• The market may react to the updated ownership, potentially causing short-term price fluctuations for INVO Bioscience stock. (INVO Bioscience, Inc.) — medium confidence, target: Within 1 week

FAQ

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o

Filing Documents

• ea192884-13ga1intra_invo.htm (SC 13G/A) — 51KB
• 0001213900-24-010331.txt ( ) — 53KB

From the Filing

SC 13G/A 1 ea192884-13ga1intra_invo.htm AMENDMENT NO. 1 TO SCHEDULE 13G UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* INVO Bioscience, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 44984F401 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: a. Rule 13d-1(b) b. Rule 13d-1(c) c. Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 6 CUSIP No. 44984F401 1. Names of Reporting Persons. Mitchell P. Kopin 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization United Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 6. Shared Voting Power 184,000 7. Sole Dispositive Power 0 8. Shared Dispositive Power 184,000 9. Aggregate Amount Beneficially Owned by Each Reporting Person 184,000 (see Item 4) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.9% (see Item 4) 12. Type of Reporting Person (See Instructions) IN; HC Page 2 of 6 CUSIP No. 44984F401 1. Names of Reporting Persons. Daniel B. Asher 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization United Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 6. Shared Voting Power 184,000 7. Sole Dispositive Power 0 8. Shared Dispositive Power 184,000 9. Aggregate Amount Beneficially Owned by Each Reporting Person 184,000 (see Item 4) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.9% (see Item 4) 12. Type of Reporting Person (See Instructions) IN; HC Page 3 of 6 CUSIP No. 44984F401 1. Names of Reporting Persons. Intracoastal Capital LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 6. Shared Voting Power 184,000 7. Sole Dispositive Power 0 8. Shared Dispositive Power 184,000 9. Aggregate Amount Beneficially Owned by Each Reporting Person 184,000 (see Item 4) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 6.9% (see Item 4) 12. Type of Reporting Person (See Instructions) OO Page 4 of 6 This Amendment No. 1 is being filed jointly by the Reporting Persons and amends the Schedule 13G initially filed by the Reporting Persons with the Securities and Exchange Commission (the “ SEC ”) on August 11, 2023 (the “ Schedule 13G ”). Except as set forth below, all Items of the Schedule 13G remain unchanged. All capitalized terms not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13G. Item 4. Ownership. (a) and (b): As of the close of business on December 31, 2023, each of the Reporting Persons may have been deemed to have beneficial ownership of 184,000 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (the “ Intracoastal Warrant ”), and all such shares of Common Stock in the aggregate represent beneficial 13, 2023 , as reported by the Issuer, plus (2) 184,000 shares of Common Stock issuable upon exercise of the Intracoastal Warrant. (c) Number of shares as to which each Reporting Person has: (i) Sole power to vote or to direct the vote: 0 . (ii) Shared power to vote or to direct the vote: 184,000 . (iii) Sole power to dispose or to direct the disposition of 0 . (iv) Shared power to dispose or to direct the disposition of 184,000 . Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effe

View Full Filing

View this SC 13G/A filing on SEC EDGAR